Company Filing History:
Years Active: 1993-1997
Title: Kevin F. Gironda: Innovator in Microemulsion Technology
Introduction
Kevin F. Gironda is a notable inventor based in Alpha, NJ (US), recognized for his contributions to the field of microemulsion technology. With a total of 6 patents to his name, Gironda has made significant advancements in the stabilization of 3-isothiazolone compounds, which are widely used in various applications.
Latest Patents
Among his latest patents, Gironda has developed a method for creating stable microemulsions of certain 3-isothiazolone compounds. This innovation involves dilute solutions of 0.5 to about 5% by weight of at least one 3-isothiazolone, specifically 5-chloro-2-methyl-4-isothazolin-3-one and 2-methyl-4-isothazolin-3-one. These solutions are stabilized without the use of inorganic metal salts or hydrogen peroxide by forming a microemulsion composition with organic solvents that have less than 6 percent by weight solubility in water, along with anionic surfactants and optionally, non-ionic surfactants. Additionally, he has developed a method for stabilizing solutions of 3-isothiazolone compounds using a stabilizing compound of a specific formula, which includes compositions that comprise the 3-isothiazolone compound, solvent, and stabilizing compound.
Career Highlights
Kevin F. Gironda has built a successful career at Rohm and Haas Company, where he has been instrumental in advancing chemical technologies. His work has not only contributed to the company's portfolio but has also had a lasting impact on the industry.
Collaborations
Throughout his career, Gironda has collaborated with esteemed colleagues such as George H. Redlich and Francis T. Letterio. These partnerships have fostered innovation and have been pivotal in the development of his patented technologies.
Conclusion
Kevin F. Gironda stands out as a significant figure in the realm of microemulsion technology, with a focus on 3-isothiazolone compounds. His innovative patents and contributions to Rohm and Haas Company highlight his dedication to advancing chemical solutions.